Mental Health Issues Common Among UK MPs

A 2008 survey has revealed that mental health problems are prevalent among UK Members of Parliament (MPs). The survey found that one in five MPs had personally experienced mental health issues. This is not a new phenomenon, as even Winston Churchill, a prominent political figure, suffered from depression throughout his career. Churchill described his depression as being followed around by a black dog. The survey highlights the need for greater awareness and support for mental health issues among politicians and the wider population.

Weight gain is a common side effect of antipsychotic medications, which may be caused by various mechanisms such as 5HT2c and H1 antagonism, hyperprolactinaemia, and increased serum leptin. This weight gain is often due to increased food intake and reduced energy expenditure. Additionally, antipsychotic-induced weight gain can lead to diabetes mellitus, with females being more susceptible to metabolic side effects than males. Among antipsychotics, clozapine and olanzapine have the highest risk of weight gain, while quetiapine and risperidone have a moderate risk. On the other hand, aripiprazole, asenapine, and amisulpride (the 3 As) are associated with the least amount of weight gain.

Although individuals with executive cognitive dysfunction may receive a normal score on the MMSE, they can still experience significant impairments in their daily functioning.

Mini Mental State Exam (MMSE)

The Mini Mental State Exam (MMSE) was developed in 1975 by Folstein et al. Its original purpose was to differentiate between organic and functional disorders, but it is now mainly used to detect and track the progression of cognitive impairment. The exam is scored out of 30 and is divided into seven categories: orientation to place and time, registration, attention and concentration, recall, language, visual construction, and attention to written command. Each category has a possible score, and the total score can indicate the severity of cognitive impairment. A score equal to or greater than 27 indicates normal cognition, while scores below this can indicate severe, moderate, of mild cognitive impairment. The MMSE is a useful tool for detecting and tracking cognitive impairment.

Sleep Stages

Sleep is divided into two distinct states called rapid eye movement (REM) and non-rapid eye movement (NREM). NREM is subdivided into four stages.

Sleep stage
Approx % of time spent in stage
EEG findings
Comment

I
5%
Theta waves (4-7 Hz)
The dozing off stage. Characterized by hypnic jerks: spontaneous myoclonic contractions associated with a sensation of twitching of falling.

II
45%
Theta waves, K complexes and sleep spindles (short bursts of 12-14 Hz activity)
Body enters a more subdued state including a drop in temperature, relaxed muscles, and slowed breathing and heart rate. At the same time, brain waves show a new pattern and eye movement stops.

III
15%
Delta waves (0-4 Hz)
Deepest stage of sleep (high waking threshold). The length of stage 3 decreases over the course of the night.

IV
15%
Mixed, predominantly beta
High dream activity.

The percentage of REM sleep decreases with age.

It takes the average person 15-20 minutes to fall asleep, this is called sleep latency (characterised by the onset of stage I sleep). Once asleep one descends through stages I-II and then III-IV (deep stages). After about 90 minutes of sleep one enters REM. The rest of the sleep comprises of cycles through the stages. As the sleep progresses the periods of REM become greater and the periods of NREM become less. During an average night’s sleep one spends 25% of the sleep in REM and 75% in NREM.

REM sleep has certain characteristics that separate it from NREM

Characteristics of REM sleep

– Autonomic instability (variability in heart rate, respiratory rate, and BP)
– Loss of muscle tone
– Dreaming
– Rapid eye movements
– Penile erection

Deafness:

(No information provided on deafness in relation to sleep stages)

Elevated levels of creatine phosphokinase (CPK) are observed in NMS.

Serotonin Syndrome and Neuroleptic Malignant Syndrome are two conditions that can be difficult to differentiate. Serotonin Syndrome is caused by excess serotonergic activity in the CNS and is characterized by neuromuscular abnormalities, altered mental state, and autonomic dysfunction. On the other hand, Neuroleptic Malignant Syndrome is a rare acute disorder of thermoregulation and neuromotor control that is almost exclusively caused by antipsychotics. The symptoms of both syndromes can overlap, but there are some distinguishing clinical features. Hyper-reflexia, ocular clonus, and tremors are more prominent in Serotonin Syndrome, while Neuroleptic Malignant Syndrome is characterized by uniform ‘lead-pipe’ rigidity and hyporeflexia. Symptoms of Serotonin Syndrome usually resolve within a few days of stopping the medication, while Neuroleptic Malignant Syndrome can take up to 14 days to remit with appropriate treatment. The following table provides a useful guide to the main differentials of Serotonin Syndrome and Neuroleptic Malignant Syndrome.

Neurotransmitters are substances used by neurons to communicate with each other and with target tissues. They are synthesized and released from nerve endings into the synaptic cleft, where they bind to receptor proteins in the cellular membrane of the target tissue. Neurotransmitters can be classified into different types, including small molecules (such as acetylcholine, dopamine, norepinephrine, serotonin, and GABA) and large molecules (such as neuropeptides). They can also be classified as excitatory or inhibitory. Receptors can be ionotropic or metabotropic, and the effects of neurotransmitters can be fast of slow. Some important neurotransmitters include acetylcholine, dopamine, GABA, norepinephrine, and serotonin. Each neurotransmitter has a specific synthesis, breakdown, and receptor type. Understanding neurotransmitters is important for understanding the function of the nervous system and for developing treatments for neurological and psychiatric disorders.

Modafinil: A Psychostimulant for Wakefulness and Attention Enhancement

Modafinil is a type of psychostimulant that is known to improve wakefulness, attention, and vigilance. Although it is similar to amphetamines, it does not produce the same euphoric effects and is not associated with dependence of tolerance. Additionally, it does not seem to cause psychosis. Modafinil is approved for the treatment of narcolepsy, obstructive sleep apnea, and chronic shift work. It is also suggested as an adjunctive treatment for depression by the Maudsley. Recently, it has gained popularity as a smart drug due to its potential to enhance cognitive functioning in healthy individuals.

Declarations

The World Medical Association has established global ethical standards through various declarations. These include:

Declaration of Geneva: This declaration was created as a revision of the Hippocratic Oath after the atrocities committed in Nazi Germany.

Declaration of Helsinki: This statement outlines ethical principles for medical research involving human subjects.

Declaration of Tokyo: This declaration states that doctors should not participate in, condone, of allow torture, degradation, of cruel treatment of prisoners of detainees.

Declaration of Malta: This declaration provides guidance to doctors treating individuals on hunger strike.

Declaration of Lisbon: This international statement outlines the rights of patients.

Declaration of Ottawa: This declaration sets out the principles necessary for optimal child health.

Each of these declarations serves as a guide for medical professionals to uphold ethical standards in their practice.

Due to their increased vulnerability to anticholinergic side effects, elderly individuals are at a higher risk of experiencing delirium. The first generation of H1 antihistamines, which have a greater tendency for anticholinergic side effects, are more likely to trigger delirium in the elderly. Benadryl, an over-the-counter medication in the UK used to treat hay fever, contains diphenhydramine as its active ingredient.

Antihistamines: Types and Uses

Antihistamines are drugs that block the effects of histamine, a neurotransmitter that regulates physiological function in the gut and potentiates the inflammatory and immune responses of the body. There are two types of antihistamines: H1 receptor blockers and H2 receptor blockers. H1 blockers are mainly used for allergic conditions and sedation, while H2 blockers are used for excess stomach acid.

There are also first and second generation antihistamines. First generation antihistamines, such as diphenhydramine and promethazine, have uses in psychiatry due to their ability to cross the blood brain barrier and their anticholinergic properties. They tend to be sedating and are useful for managing extrapyramidal side effects. Second generation antihistamines, such as loratadine and cetirizine, show limited penetration of the blood brain barrier and are less sedating.

It is important to note that there are contraindications to first-generation antihistamines, including benign prostatic hyperplasia, angle-closure glaucoma, and pyloric stenosis in infants. These do not apply to second-generation antihistamines.

Depression has been found to be strongly associated with cardiovascular disease, even after controlling for other risk factors such as smoking. Studies have demonstrated that depression is an independent predictor of both fatal and non-fatal ischaemic heart disease.

The four moral principles are a useful tool in clinical practice. For instance, if a patient arrives in critical condition after a car accident and is unable to provide informed consent, the principle of beneficence requires healthcare professionals to prioritize treatment for the patient. The principle of justice may also be considered if there are many patients in need of care of if the treatment is expensive of scarce, potentially depriving others of medical attention. Non-maleficence is relevant if the treatment is likely to cause more harm than good. Respect for autonomy is important if the patient has previously expressed a desire to decline treatment in such circumstances.

The liver is responsible for metabolizing valproate, and drugs that disrupt the CYP enzymes can greatly impact its levels. Valproic acid and semi-sodium valproate are approved for treating bipolar disorder, while sodium valproate is solely approved for epilepsy.

Valproate: Forms, Doses, and Adverse Effects

Valproate comes in three forms: semi-sodium valproate, valproic acid, and sodium valproate. Semi-sodium valproate is a mix of sodium valproate and valproic acid and is licensed for acute mania associated with bipolar disorder. Valproic acid is also licensed for acute mania, but this is not consistent with the Maudsley Guidelines. Sodium valproate is licensed for epilepsy. It is important to note that doses of sodium valproate and semi-sodium valproate are not the same, with a slightly higher dose required for sodium valproate.

Valproate is associated with many adverse effects, including nausea, tremor, liver injury, vomiting/diarrhea, gingival hyperplasia, memory impairment/confusional state, somnolence, weight gain, anaemia/thrombocytopenia, alopecia (with curly regrowth), severe liver damage, and pancreatitis. Increased liver enzymes are common, particularly at the beginning of therapy, and tend to be transient. Vomiting and diarrhea tend to occur at the start of treatment and remit after a few days. Severe liver damage is most likely to occur in the first six months of therapy, with the maximum risk being between two and twelve weeks. The risk also declines with advancing age.

Valproate is a teratogen and should not be initiated in women of childbearing potential. Approximately 10% of children exposed to valproate monotherapy during pregnancy suffer from congenital malformations, with the risk being dose-dependent. The most common malformations are neural tube defects, facial dysmorphism, cleft lip and palate, craniostenosis, cardiac, renal and urogenital defects, and limb defects. There is also a dose-dependent relationship between valproate and developmental delay, with approximately 30-40% of children exposed in utero experiencing delay in their early development, such as talking and walking later, lower intellectual abilities, poor language skills, and memory problems. There is also a thought to be a 3-fold increase of autism in children exposed in utero.

Genomics: Understanding DNA, RNA, Transcription, and Translation

Deoxyribonucleic acid (DNA) is a molecule composed of two chains that coil around each other to form a double helix. DNA is organised into chromosomes, and each chromosome is made up of DNA coiled around proteins called histones. RNA, on the other hand, is made from a long chain of nucleotide units and is usually single-stranded. RNA is transcribed from DNA by enzymes called RNA polymerases and is central to protein synthesis.

Transcription is the synthesis of RNA from a DNA template, and it consists of three main steps: initiation, elongation, and termination. RNA polymerase binds at a sequence of DNA called the promoter, and the transcriptome is the collection of RNA molecules that results from transcription. Translation, on the other hand, refers to the synthesis of polypeptides (proteins) from mRNA. Translation takes place on ribosomes in the cell cytoplasm, where mRNA is read and translated into the string of amino acid chains that make up the synthesized protein.

The process of translation involves messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). Transfer RNAs, of tRNAs, connect mRNA codons to the amino acids they encode, while ribosomes are the structures where polypeptides (proteins) are built. Like transcription, translation also consists of three stages: initiation, elongation, and termination. In initiation, the ribosome assembles around the mRNA to be read and the first tRNA carrying the amino acid methionine. In elongation, the amino acid chain gets longer, and in termination, the finished polypeptide chain is released.

Long-term memories prior to anterograde amnesia are unaffected, as the condition only affects the formation of new memories. Unfortunately, amnesia cannot be treated as it involves damage to neurons. Lacunar amnesia refers to the loss of memory for a specific event, with the term lacuna meaning a gap of missing part in Latin. Retrograde amnesia typically involves damage to structures in the medial temporal lobe, such as the hippocampus, rather than the cerebellum. Source amnesia is characterized by the inability to recall the context in which previously learned information was acquired, while still retaining the factual knowledge.

Understanding Amnesia: Types and Causes

Amnesia is a memory deficit that can be categorized into two types: anterograde and retrograde. Anterograde amnesia refers to the inability to create new memories, while retrograde amnesia refers to the loss of memory for information acquired before the onset of amnesia. The damage to the hippocampus and medial temporal lobe is often associated with amnesia. Source amnesia is the inability to remember where of how previously learned information was acquired. Psychogenic amnesia is characterized by sudden retrograde episodic memory loss, while semantic amnesia affects semantic memory and language use. Transient global amnesia is a condition that affects those over 50 and spontaneously resolves within 24 hours, with no clear cause identified. Understanding the types and causes of amnesia can help in its diagnosis and treatment.

Ribot’s Law and Jost’s Law: Understanding Memory Consolidation and Forgetting

Ribot’s Law, also known as the law of retrograde amnesia, suggests that recent memories are more likely to be lost than older ones. This implies that memories need time to consolidate and become more resistant to forgetting. Ribot observed that people who experience traumatic events often lose memories leading up to the event, but older memories are preserved. This pattern is also observed in patients with Alzheimer’s disease, where the saying goes, you lose first what you learn last.

Jost’s Law of forgetting complements Ribot’s Law by stating that if two memories are of the same strength but different ages, the older memory will decay more slowly than the younger one. Together, these laws suggest that memory consolidation is a gradual process that takes time, and once memories are consolidated, they become more resistant to forgetting. Understanding these laws can help us better understand how memories are formed, retained, and lost over time.

Genomic Imprinting and its Role in Psychiatric Disorders

Genomic imprinting is a phenomenon where a piece of DNA behaves differently depending on whether it is inherited from the mother of the father. This is because DNA sequences are marked of imprinted in the ovaries and testes, which affects their expression. In psychiatry, two classic examples of genomic imprinting disorders are Prader-Willi and Angelman syndrome.

Prader-Willi syndrome is caused by a deletion of chromosome 15q when inherited from the father. This disorder is characterized by hypotonia, short stature, polyphagia, obesity, small gonads, and mild mental retardation. On the other hand, Angelman syndrome, also known as Happy Puppet syndrome, is caused by a deletion of 15q when inherited from the mother. This disorder is characterized by an unusually happy demeanor, developmental delay, seizures, sleep disturbance, and jerky hand movements.

Overall, genomic imprinting plays a crucial role in the development of psychiatric disorders. Understanding the mechanisms behind genomic imprinting can help in the diagnosis and treatment of these disorders.

Serotonin (5-hydroxytryptamine, 5-HT) receptors are primarily G protein receptors, except for 5-HT3, which is a ligand-gated receptor. It is important to remember that 5-HT3 is most commonly associated with nausea. Additionally, 5-HT7 is linked to circadian rhythms. The stimulation of 5-HT2 receptors is believed to be responsible for the side effects of insomnia, agitation, and sexual dysfunction that are associated with the use of selective serotonin reuptake inhibitors (SSRIs).

Notable Psychiatrists and their Contributions

Kurt Schneider, a German psychiatrist, is renowned for his work on schizophrenia diagnosis. He identified the ‘first rank symptoms’ of schizophrenia, which include hallucinations, delusions, and thought disorders. Henderson, on the other hand, conducted research on personality disorders and categorized psychopathy into aggressive, inadequate, and creative subtypes. Nathan Ackerman, an American psychiatrist, was a pioneer in the development of family therapy. He introduced the concept of treating the family as a unit rather than just the individual. Thomas Sydenham, a 17th-century physician, was the first to describe hysteria as a disease of the mind. Lastly, Maxwell Jones developed the concept of the therapeutic community, which emphasizes the importance of social interaction and support in the treatment of mental illness.

Multisystem Atrophy: A Parkinson Plus Syndrome

Multisystem atrophy is a type of Parkinson plus syndrome that is characterized by three main features: Parkinsonism, autonomic failure, and cerebellar ataxia. It can present in three different ways, including Shy-Drager Syndrome, Striatonigral degeneration, and Olivopontocerebellar atrophy, each with varying degrees of the three main features.

Macroscopic features of multisystem atrophy include pallor of the substantia nigra, greenish discoloration and atrophy of the putamen, and cerebellar atrophy. Microscopic features include the presence of Papp-Lantos bodies, which are alpha-synuclein inclusions found in oligodendrocytes in the substantia nigra, cerebellum, and basal ganglia.

Overall, multisystem atrophy is a complex and debilitating condition that affects multiple systems in the body, leading to a range of symptoms and challenges for patients and their caregivers.

Valproate can cause weight gain, which is particularly concerning when it is combined with other medications like clozapine.

Valproate: Forms, Doses, and Adverse Effects

Valproate comes in three forms: semi-sodium valproate, valproic acid, and sodium valproate. Semi-sodium valproate is a mix of sodium valproate and valproic acid and is licensed for acute mania associated with bipolar disorder. Valproic acid is also licensed for acute mania, but this is not consistent with the Maudsley Guidelines. Sodium valproate is licensed for epilepsy. It is important to note that doses of sodium valproate and semi-sodium valproate are not the same, with a slightly higher dose required for sodium valproate.

Valproate is associated with many adverse effects, including nausea, tremor, liver injury, vomiting/diarrhea, gingival hyperplasia, memory impairment/confusional state, somnolence, weight gain, anaemia/thrombocytopenia, alopecia (with curly regrowth), severe liver damage, and pancreatitis. Increased liver enzymes are common, particularly at the beginning of therapy, and tend to be transient. Vomiting and diarrhea tend to occur at the start of treatment and remit after a few days. Severe liver damage is most likely to occur in the first six months of therapy, with the maximum risk being between two and twelve weeks. The risk also declines with advancing age.

Valproate is a teratogen and should not be initiated in women of childbearing potential. Approximately 10% of children exposed to valproate monotherapy during pregnancy suffer from congenital malformations, with the risk being dose-dependent. The most common malformations are neural tube defects, facial dysmorphism, cleft lip and palate, craniostenosis, cardiac, renal and urogenital defects, and limb defects. There is also a dose-dependent relationship between valproate and developmental delay, with approximately 30-40% of children exposed in utero experiencing delay in their early development, such as talking and walking later, lower intellectual abilities, poor language skills, and memory problems. There is also a thought to be a 3-fold increase of autism in children exposed in utero.

Genetics plays a role in the development of Alzheimer’s disease, with different genes being associated with early onset and late onset cases. Early onset Alzheimer’s, which is rare, is linked to three genes: amyloid precursor protein (APP), presenilin one (PSEN-1), and presenilin two (PSEN-2). The APP gene, located on chromosome 21, produces a protein that is a precursor to amyloid. The presenilins are enzymes that cleave APP to produce amyloid beta fragments, and alterations in the ratios of these fragments can lead to plaque formation. Late onset Alzheimer’s is associated with the apolipoprotein E (APOE) gene on chromosome 19, with the E4 variant increasing the risk of developing the disease. People with Down’s syndrome are also at high risk of developing Alzheimer’s due to inheriting an extra copy of the APP gene.

Understanding Endophenotypes in Psychiatry

Endophenotypes are measurable components that are not visible to the naked eye, but are present along the pathway between disease and distal genotype. These components may be neurophysiological, biochemical, endocrinological, neuroanatomical, cognitive, of neuropsychological. They provide simpler clues to genetic underpinnings than the disease syndrome itself, making genetic analysis more straightforward and successful.

Endophenotypes are important in biological psychiatry research as they specifically require heritability and state independence. They must segregate with illness in the general population, be heritable, manifest whether illness is present of in remission, cosegregate with the disorder within families, be present at a higher rate within affected families than in the general population, and be a characteristic that can be measured reliably and is specific to the illness of interest.

Understanding endophenotypes is crucial in delineating the pathophysiology of mental illness, as genes are the biological bedrock of these disorders. By identifying and measuring endophenotypes, researchers can gain insight into the underlying genetic causes of mental illness and develop more effective treatments.

NMS can be identified by three primary symptoms: hyperthermia, rigidity, and elevated creatine phosphokinase concentration. If these symptoms are not present, the diagnosis of NMS should be reconsidered as other symptoms may be present in patients taking neuroleptics without having NMS. This information was reported by P Adnet in the British Journal of Anaesthesia in 2000.

Serotonin Syndrome and Neuroleptic Malignant Syndrome are two conditions that can be difficult to differentiate. Serotonin Syndrome is caused by excess serotonergic activity in the CNS and is characterized by neuromuscular abnormalities, altered mental state, and autonomic dysfunction. On the other hand, Neuroleptic Malignant Syndrome is a rare acute disorder of thermoregulation and neuromotor control that is almost exclusively caused by antipsychotics. The symptoms of both syndromes can overlap, but there are some distinguishing clinical features. Hyper-reflexia, ocular clonus, and tremors are more prominent in Serotonin Syndrome, while Neuroleptic Malignant Syndrome is characterized by uniform ‘lead-pipe’ rigidity and hyporeflexia. Symptoms of Serotonin Syndrome usually resolve within a few days of stopping the medication, while Neuroleptic Malignant Syndrome can take up to 14 days to remit with appropriate treatment. The following table provides a useful guide to the main differentials of Serotonin Syndrome and Neuroleptic Malignant Syndrome.

Altered Perceptual Experiences

Disorders of perception can be categorized into sensory distortions and sensory deceptions. Sensory distortions involve changes in the intensity, spatial form, of quality of a perception. Examples include hyperaesthesia, hyperacusis, and micropsia. Sensory deceptions, on the other hand, involve new perceptions that are not based on any external stimulus. These include illusions and hallucinations.

Illusions are altered perceptions of a stimulus, while hallucinations are perceptions in the absence of a stimulus. Completion illusions, affect illusions, and pareidolic illusions are examples of illusions. Auditory, visual, gustatory, olfactory, and tactile hallucinations are different types of hallucinations. Pseudohallucinations are involuntary and vivid sensory experiences that are interpreted in a non-morbid way. They are different from true hallucinations in that the individual is able to recognize that the experience is an internally generated event.

Understanding the different types of altered perceptual experiences is important in the diagnosis and treatment of various mental health conditions.

The CAMDEX assessment is not effective in detecting dementia in adults with learning disabilities, whose developmental ages are typically between 2 and 10 years. However, the Dementia Questionnaire for People with Learning Disabilities (DLD) is a useful tool for early detection of dementia in this population. For individuals with Down’s syndrome, an adapted version of the CAMDEX called the CAMDEX-DS can be utilized.

Assessment of Dementia in Down’s Syndrome

Individuals with Down’s syndrome are at a higher risk of developing Alzheimer’s disease. However, the commonly used MMSE test is not effective in assisting diagnosis in this population. Instead, two alternative tests are recommended: the Dementia Questionnaire for people with Learning Disabilities (DLD), previously known as the Dementia Questionnaire for Persons with Mental Retardation (DMR), and the Dementia Scale for Down Syndrome (DSDS). These tests are specifically designed to assess cognitive decline in individuals with Down’s syndrome and can aid in the early detection and management of dementia in this population.

The pineal gland secretes melatonin, while the adrenal glands secrete cortisol, aldosterone, adrenaline, and noradrenaline. The release of pituitary hormones is regulated by the hypothalamus, which synthesizes and secretes releasing hormones. Additionally, the parathyroid glands secrete parathyroid hormone (PTH).

It may be more effective to ask open-ended questions at the beginning of an interview to gather as much information as possible. Closed questions can be used later in the interview to clarify specific points. However, it is important to avoid leading questions that may influence the patient’s response. For example, instead of asking if the patient feels worse in the morning, a more open question such as Can you describe your mood throughout the day? may be more appropriate.

Ethical Principles for Human Experimentation and Research

The Declaration of Helsinki is a set of ethical principles that govern human experimentation and research. It was created by the World Medical Association and first adopted in 1964. The Declaration builds on the Nuremberg Code, which is a set of ethical principles for human experimentation that was developed after World War II. Additionally, the European Convention on Human Rights applies to human rights and freedoms in Europe.

Genomics: Understanding DNA, RNA, Transcription, and Translation

Deoxyribonucleic acid (DNA) is a molecule composed of two chains that coil around each other to form a double helix. DNA is organised into chromosomes, and each chromosome is made up of DNA coiled around proteins called histones. RNA, on the other hand, is made from a long chain of nucleotide units and is usually single-stranded. RNA is transcribed from DNA by enzymes called RNA polymerases and is central to protein synthesis.

Transcription is the synthesis of RNA from a DNA template, and it consists of three main steps: initiation, elongation, and termination. RNA polymerase binds at a sequence of DNA called the promoter, and the transcriptome is the collection of RNA molecules that results from transcription. Translation, on the other hand, refers to the synthesis of polypeptides (proteins) from mRNA. Translation takes place on ribosomes in the cell cytoplasm, where mRNA is read and translated into the string of amino acid chains that make up the synthesized protein.

The process of translation involves messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). Transfer RNAs, of tRNAs, connect mRNA codons to the amino acids they encode, while ribosomes are the structures where polypeptides (proteins) are built. Like transcription, translation also consists of three stages: initiation, elongation, and termination. In initiation, the ribosome assembles around the mRNA to be read and the first tRNA carrying the amino acid methionine. In elongation, the amino acid chain gets longer, and in termination, the finished polypeptide chain is released.

Fahr’s syndrome is a rare condition where calcium deposits accumulate in the brain’s basal ganglia, which control movement. This can lead to neuropsychiatric symptoms such as dementia, psychosis, and behavioral changes. The pituitary gland, located at the base of the brain, produces hormones that affect various parts of the body. The occipital lobe is responsible for vision, while the cerebellum controls motor coordination, balance, and muscle tone. The hippocampus, located in the medial temporal lobe, is involved in spatial navigation and memory.